XML 64 R49.htm IDEA: XBRL DOCUMENT v3.22.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Disaggregation of Revenue (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Summary Of Significant Accounting Policies [Line Items]      
Net sales $ 12,784 $ 11,673 $ 11,362
Renal Care      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 3,900 3,757 3,639
Medication Delivery      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 2,880 2,691 2,739
Pharmaceuticals      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 2,291 2,098 2,119
Clinical Nutrition      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 964 910 860
Advanced Surgery      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 977 886 875
Acute Therapies      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 782 740 535
BioPharma Solutions      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 669 486 469
Patient support systems      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 115 0 0
Front line care      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 70 0 0
Surgical solutions      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 27 0 0
Other      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 109 105 126
U.S.      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 5,180 4,878 4,826
U.S. | Renal Care      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 890 848 791
U.S. | Medication Delivery      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 1,859 1,738 1,762
U.S. | Pharmaceuticals      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 753 849 904
U.S. | Clinical Nutrition      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 343 330 308
U.S. | Advanced Surgery      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 545 516 533
U.S. | Acute Therapies      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 287 286 184
U.S. | BioPharma Solutions      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 273 234 257
U.S. | Patient support systems      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 86 0 0
U.S. | Front line care      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 51 0 0
U.S. | Surgical solutions      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 12 0 0
U.S. | Other      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 81 77 87
International      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 7,604 6,795 6,536
International | Renal Care      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 3,010 2,909 2,848
International | Medication Delivery      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 1,021 953 977
International | Pharmaceuticals      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 1,538 1,249 1,215
International | Clinical Nutrition      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 621 580 552
International | Advanced Surgery      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 432 370 342
International | Acute Therapies      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 495 454 351
International | BioPharma Solutions      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 396 252 212
International | Patient support systems      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 29 0 0
International | Front line care      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 19 0 0
International | Surgical solutions      
Summary Of Significant Accounting Policies [Line Items]      
Net sales 15 0 0
International | Other      
Summary Of Significant Accounting Policies [Line Items]      
Net sales $ 28 $ 28 $ 39